Background: The number of HIV-infected children starting antiretroviral treatment (ART) has
Introduction
At the end of 2012, 630 000 children were receiving ART in low-and middle-income countries [1] and treatment outcomes were comparable or better than those reported among children treated in high-income countries [2] . However, researchers have highlighted the necessity to describe the cascade of patients enrolled in HIV care before the start of ART to appropriately assess the overall performance of HIV programs [3] . Several studies have reported rates of program attrition among HIV-infected children in Sub-Saharan Africa [4] [5] [6] [7] [8] [9] [10] . Descriptions of characteristics of pediatric patients at program enrolment and of the dynamics of dropping out before the start of ART are nevertheless scarce. In Médecins Sans Frontières (MSF)-supported HIV programs between 5% and 51% of children currently followed have not yet started ART (unpublished internal reports). We previously reported a high dropout rate of adult patients before the start of therapy, especially early after program enrolment [11] . We have now conducted a longitudinal study to describe the cascade of care, characteristics, outcomes and associated risk factors of patients aged 5 to 14 years before the start of ART.
Methods

Study design and population
We analyzed electronic medical records from HIV-positive patients aged 5-14 years, and treated in the four HIV programs supported by MSF-France in Sub-Saharan Africa (two in Kenya, one in an urban slum and one in a rural district hospital; one highly decentralized in a rural district of Patients were clinically evaluated at enrolment and every 3 to 6 months, depending on the level of immunosuppression. National guidelines for patient management were followed and encompassed clinical staging and nutritional status monitoring, as recommended by the World Health Organization (WHO). At program entry CD4 cell count testing was used to assess ART eligibility in patients with WHO clinical stage 1 or 2, and then every 6 months (3 months for patients with counts <500 cells/µL). No routine viral load (VL) monitoring or contact tracing were done. Eligibility criteria for ART start evolved over time, following changes in WHO recommendations.
Statistical analysis
Patient study follow-up started at the date of program inclusion and ended at the earliest of the following events: death, transfer-out, ART initiation, or date of last clinic visit. Loss to follow-up (LFU) was defined as missing an appointment for more than 6 months at the database censoring date, in patients not transferred outside the program or reported as dead [12] .
Patient characteristics at HIV care enrolment were described using frequency and percentages for categorical variables and median and interquartile range (IQR) for continuous variables.
Comparisons were made using Chi 2, and Wilcoxon or Kruskal-Wallis tests, respectively. For baseline clinico-immunologic covariates, the closest record within 3 months of enrolment was used. A low BMI was defined as a BMI <18.5 kg/m 2 [13] .
Results
A total of 2,244 children were included in the analysis (Figure 1 and LFU (p=0.502).
7
ART cascade of care is displayed in Figure 1 . ART eligibility at enrolment could be determined for the periods 0-6 and 6-60 months respectively; Table 3 ). Compared to patients not eligible for ART, eligible patients had increased risk of being LFU (aHR of 1.92, 95%CI 1.30-2.82 and 2.31, 95%CI 1.49-3.56, respectively for the two periods).
Sensitivity analysis excluding patients with missing data showed similar results both for risk factors of pre-ART mortality and LFU.
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Discussion
This multicentric study conducted among 2,244 children who received HIV care in four large HIV programs in sub-Saharan Africa showed high pre-ART mortality and LFU rates among patients eligible and non-eligible for ART, especially during the early months after program entry. During the first 6 months of pre-ART care children initially eligible for ART were 14 times more likely to die and 2 times more likely to be LFU than those ineligible.
The observed delay in ART initiation among eligible children was approximately two months.
This is similar to delays reported in rural Zambia [5] In our study, over time, a greater proportion of patients had known ART eligibility status at program entry and among these the proportion of patients initially ART eligible decreased.
Patients referred by in/out patient departments were less likely to die than those referred by the In our evaluation, initial ART eligibility accounted for 62% of deaths and 44% of LFU, and 39.7% of deaths occurred within one month of inclusion. In two programs in Cambodia [4] , 79%
of deaths occurred among eligible children not yet started on ART, and 25% of these within one month after eligibility determination. In rural Zambia, 77.8% of pre-ART deaths were reported amongst eligible children [5] and the three-month mortality rate post-enrolment was 4.5/100
person-years, which is half the rate found in eligible children in our study. Analysis of a small cohort of eligible children in Gambia showed high pre-ART mortality and attrition rates (25.7/100 and 115.7/100 person-years, respectively) [6] . No risk factors for death were identified, but young age (less than 2 years) and advance clinical stage were independently associated with increased program attrition. Our findings also identified advanced HIV disease as predictor of both early and late deaths, factor associated with increased mortality during the early months of ART use [8, [15] [16] [17] [18] [19] .
In the absence of ART it is estimated that 62%-89% of infected children would have died by the age of 2 years [20] [21] [22] . Children diagnosed and treated at older ages are likely to largely 
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for all the members of a family could help to improve program retention. In addition, we observed an important proportion of children with unknown eligibility status who were lost to follow-up immediately after their first visit. By not returning to care, patients might have missed opportunities for further investigations (e.g. when point-of-care CD4 count testing was not available), and so their eligibility could not be determined. Children with apparent good health (stage 1/2) and without prescribed treatment might also not return to care after the first visit.
Availability of point-of-care CD4 count testing and provision of adequate counselling to guardians and children on HIV and the need for regular medical monitoring are important to reduce high rates of early follow-up.
Strengths of this analysis include its multicentric nature, a good electronic medical system covering pre-ART care and its sample size. Several limitations are to be considered when examining our findings. First, the reported median time between HIV testing and program enrolment might be biased since it is calculated within the group of patients who enrolled in HIV care. However, we would expect this bias to be small given that counsellors referred patients for program enrollment just after disclosing their HIV status. Second, CD4 cell count and clinical stage data were missing for some patients. Nevertheless, the results of the complete case analysis showed consistent results. Third, information related to some potential confounding factors (e.g.
home distance to health facilities, parental vital status, or patient hemoglobin) was not available for analysis. Furthermore, death was incompletely ascertained and a non-negligible proportion of patients LFU may have died [32], leading to an underestimation of mortality and overestimation of LFU. However, competing risk analyses showed concordant results.
In conclusion, our findings highlight the challenges and unmet needs related to the provision of 
